Jan 08, 2018 12:01 pm UTC| Business
VANCOUVER, British Columbia, Jan. 08, 2018 -- Isodiol International Inc., (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of...
Jan 08, 2018 12:01 pm UTC| Business
HONG KONG, Jan. 08, 2018 -- SPI Energy Co., Ltd. (“SPI Energy” or the “Company”) (Nasdaq:SPI), a global clean energy market place for business, residential, government and utility customers and investors, today...
Jan 08, 2018 12:01 pm UTC| Business
-- Intepirdine Program to be Discontinued Based on MINDSET, HEADWAY, and Gait and Balance Study Results ---- Company to Advance to Larger Confirmatory Nelotanserin DLB Study Focused on Motor Function and Psychosis ----...
Jan 08, 2018 12:01 pm UTC| Business
CAMBRIDGE, Mass., Jan. 08, 2018 -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis...
Destination XL Group, Inc. Announces Holiday Sales Results
Jan 08, 2018 12:01 pm UTC| Business
CANTON, Mass., Jan. 08, 2018 -- Destination XL Group, Inc. (NASDAQ:DXLG), the largest omni-channel specialty retailer of big tall men's apparel, today announced that total sales for the 9-week holiday sales period...
Melinta Therapeutics Completes Acquisition of The Medicines Company’s Infectious Disease Portfolio
Jan 08, 2018 12:01 pm UTC| Business
— Expands portfolio to four marketed antibiotics, with peak sales potential over $1 billion —— Creates premier commercial stage global antibiotic franchise with the addition of Vabomere™(meropenem and vaborbactam),...
Merus and Simcere Announce Strategic Collaboration on Multiple Bispecific Antibodies
Jan 08, 2018 12:01 pm UTC| Business
UTRECHT, Netherlands and NANJING, China, Jan. 08, 2018 -- Merus (Nasdaq:MRUS) and Simcere Pharmaceutical Group today announced that Merus has agreed to grant Simcere an exclusive license to develop and commercialize in...